Table 1.
Cross Sectional Imaging | Features | Limitations | Future Perspectives |
---|---|---|---|
MRE | No radiation High contrast resolution Possibility of performing fluoro-magnetic resonance Can be combined with perianal imaging High accuracy for severe fibrosis identification |
Time consuming Intravenous and oral contrast agents Longer scanning time than CTE Less robust than CTE Lower patient compliance than CTE Availability |
Validation in more robust clinical trials Combination with radiomics |
DWI-MR | Short-time Possible with standard MR scanners No intravenous contrast Qualitative and quantitative analysis High accuracy for inflammation and penetrating complications in IBD High accuracy for severe fibrosis identification |
Lack of anatomic details Low reproducibility of ADC Availability |
Promising results to be confirmed in more robust clinical trials |
DKI-MR | More physiologic imaging No intravenous contrast High accuracy for inflammation Correlation with different fibrosis grades |
Few data | Promising results to be confirmed in more robust clinical trials |
MT-MR | No intravenous contrast agent Correlation with different fibrosis grades Higher accuracy for fibrosis than MRE with or without DWI |
Few data | Promising results to be confirmed in more robust clinical trials |
CTE | Accessible Fast Robust Better spatial resolution than MRE |
Radiation | Combination with radiomics Reduction in the radiation dose with high-standard dual-source or ultra-high-pitch CT scanners and iterative reconstruction systems |
PET/CTE PET/MRE |
In combination with CTE or MRE adds functional data | Radiation (labeled marker; CTE) High cost Limited availability Lack of anatomic details |
The disadvantages and lack of advantages when compared to CTE and MRE may hinder further developments |
USE US-SWI |
Real-time visualization of tissue stiffness | Operator dependent Not easy to interpret More difficult to compare current examination with previous studies Heterogeneous data |
Promising results to be confirmed in more robust clinical trials |
CEUS | Severe fibrosis identification when associated to elastography techniques | Operator dependent Not easy to interpret More difficult to compare current examination with previous studies Heterogeneous data |
Promising results to be confirmed in more robust clinical trials |
CTE: computed tomography enterography; CEUS: contrast-enhanced ultrasonography; DKI-MR: diffusion kurtosis imaging–magnetic resonance; DWI-MR: diffusion-weighted imaging–magnetic resonance; MRE: magnetic resonance enterography; MT-MR: magnetization transfer–magnetic resonance; PET/CTE: positron emission tomography/CTE; PET/MRE: positron emission tomography/MRE; USE: ultrasound strain elastography; US-SWI: ultrasound–shear wave imaging.